Peter Radovich - Feb 3, 2025 Form 4 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)

Role
PRESIDENT AND COO
Signature
/s/ Judit Ryvkin, Attorney-in-Fact
Stock symbol
MIRM
Transactions as of
Feb 3, 2025
Transactions value $
-$126,681
Form type
4
Date filed
2/4/2025, 05:30 PM
Previous filing
Jan 27, 2025
Next filing
Mar 5, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MIRM Common Stock Sale -$127K -2.63K -8.88% $48.22 27K Feb 3, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units.